Vistagen Therapeutics Inc Sustainability Reports

VistaGen Therapeutics Inc. specializes in the development of innovative stem cell technologies and novel small molecule drugs to address central nervous system disorders and diseases.

Sector: Health Care

Country: United States

Exchange: Nasdaq Stock Market

ISIN: US92840H2022

3 reports from 2021 to 2025

Company Profile

Vistagen Therapeutics Inc

VistaGen Therapeutics Inc. specializes in the development of innovative stem cell technologies and novel small molecule drugs to address central nervous system disorders and diseases.

MIC

 

Ticker

 

ISIN

 

Website

www.vistagen.com

Reports

Available reports